Sign in to view content

Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments

Rehan M. Hussain, MD

Video
Published 2021

Related

The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During the COVID-19 Pandemic
Sunir J. Garg, MD, FACS, FASRS
Annual Meeting Talks
2021
Predicting Long-term Response to Ranibizumab After Three Injections in Patients With Age-Related Macular Degeneration
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2020
Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients
Henry A Leder, MD
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more